American Century Companies Inc. Boosts Stake in Innophos Holdings, Inc. (IPHS)

American Century Companies Inc. increased its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 12.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 772,467 shares of the specialty chemicals company’s stock after purchasing an additional 87,593 shares during the period. American Century Companies Inc. owned approximately 3.96% of Innophos worth $36,097,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. BlackRock Inc. raised its position in Innophos by 3.8% in the 2nd quarter. BlackRock Inc. now owns 2,432,009 shares of the specialty chemicals company’s stock valued at $106,620,000 after buying an additional 89,360 shares during the last quarter. Vanguard Group Inc. raised its position in Innophos by 2.9% in the 2nd quarter. Vanguard Group Inc. now owns 1,926,577 shares of the specialty chemicals company’s stock valued at $84,460,000 after buying an additional 54,505 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Innophos by 1.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 988,323 shares of the specialty chemicals company’s stock valued at $48,616,000 after buying an additional 14,862 shares during the last quarter. Frontier Capital Management Co. LLC raised its position in Innophos by 1.5% in the 3rd quarter. Frontier Capital Management Co. LLC now owns 869,238 shares of the specialty chemicals company’s stock valued at $42,758,000 after buying an additional 12,808 shares during the last quarter. Finally, Segall Bryant & Hamill LLC increased its position in shares of Innophos by 11.0% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 820,518 shares of the specialty chemicals company’s stock valued at $40,361,000 after purchasing an additional 81,550 shares during the last quarter. Institutional investors own 96.54% of the company’s stock.

Shares of Innophos Holdings, Inc. (IPHS) opened at $43.25 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.49 and a current ratio of 2.86. The stock has a market capitalization of $844.63, a price-to-earnings ratio of 19.84 and a beta of 0.76. Innophos Holdings, Inc. has a 12-month low of $40.45 and a 12-month high of $58.22.

Several brokerages have recently issued reports on IPHS. BidaskClub raised Innophos from a “sell” rating to a “hold” rating in a research report on Thursday, December 14th. Zacks Investment Research lowered Innophos from a “buy” rating to a “hold” rating in a research report on Wednesday, January 3rd. Finally, KeyCorp reaffirmed a “hold” rating on shares of Innophos in a research report on Wednesday, November 1st.

TRADEMARK VIOLATION WARNING: This story was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://ledgergazette.com/2018/02/20/innophos-holdings-inc-iphs-shares-bought-by-american-century-companies-inc.html.

Innophos Profile

Innophos Holdings, Inc is an international producer of specialty ingredient solutions that deliver for the food, health, nutrition and industrial markets. The Company’s segments include Food, Health and Nutrition, Industrial Specialties and Other. It offers a range of product categories, such as asphalt, catalyst, fertilizer salts, liquid phosphate, phosphate salt, phosphoric acid, polyphosphoric acid, sodium bicarbonate, and food blends.

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply